Understanding Polycythemia Vera

ruxolitinib and pegasys for treating MPNs
Dr Mesa and Dr Mikhael Discuss Latest MPN Research 2017
January 29, 2017
Immunofluorescence of single human cell stained grown in tissue culture, stained with multiple antibodies and visualized via confocal microscopy
A New Therapeutic Target for Myelofibrosis is cause for Gli
June 5, 2017

Understanding Polycythemia Vera

understanding polycythemia vera

Understanding Polycythemia Vera (PV), A Rare Blood Cancer

Behind the Mystery, Polycythemia Vera

Every year, millions of patients, families and caregivers are impacted by cancer in the United States.  Some cancers are well-known, but others are quite rare. Polycythemia Vera (PV) is part of a group of rare blood cancers called Myeloproliferative Neoplasms (MPNs).  PV occurs when the body produces too many red blood cells, which causes the blood to thicken. Thickening blood could lead to clots, which can block blood flow through arteries and veins.  This in turn could result in serious health problems including a heart attack or stroke.  Join us as we discuss the diagnosis and symptoms of PV with hematologist, Dr. Shachar Peles and his patient with PV and learn more about PV and MPNs at http://www.VoicesofMPN.com.

Click Below for the Video 

Category: Behind the Mystery, Videos


Comments are closed.

MPN Cancer Connection
Malcare WordPress Security